Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice

The use of an aromatase inhibitor (AI) in combination with ovarian function suppression (OFS) has become the mainstay of adjuvant endocrine therapy in high-risk premenopausal patients with hormone receptor-positive breast cancer. Although five years of such therapy effectively reduces recurrence rat...

Full description

Bibliographic Details
Main Authors: Giuseppe Buono, Grazia Arpino, Lucia Del Mastro, Alessandra Fabi, Daniele Generali, Fabio Puglisi, Alberto Zambelli, Saverio Cinieri, Francesco Nuzzo, Vincenzo Di Lauro, Paolo Vigneri, Giampaolo Bianchini, Filippo Montemurro, Alessandra Gennari, Michelino De Laurentiis
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
breast cancer
extended endocrine treatment
premenopausal patients
Delphi study
clinical and genomic risk
ovarian function suppression
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1032166/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1032166/full

Similar Items